Yossi Maimon
2016 - Protalix BioTherapeutics
In 2016, Yossi Maimon earned a total compensation of $444.8K as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 43% decrease compared to previous year.
Compensation breakdown
| Option Awards | $93,890 |
|---|---|
| Salary | $264,696 |
| Stock Awards | $16,043 |
| Other | $70,153 |
| Total | $444,782 |
Maimon received $264.7K in salary, accounting for 60% of the total pay in 2016.
Maimon also received $93.9K in option awards, $16K in stock awards and $70.2K in other compensation.
Rankings
In 2016, Yossi Maimon's compensation ranked 11,594th out of 14,075 executives tracked by ExecPay. In other words, Maimon earned more than 17.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,594 out of 14,075 | 18th |
Division Manufacturing | 4,519 out of 5,488 | 18th |
Major group Chemicals And Allied Products | 1,615 out of 1,900 | 15th |
Industry group Drugs | 1,308 out of 1,543 | 15th |
Industry Biological Products, Except Diagnostic Substances | 237 out of 287 | 17th |
Source: SEC filing on March 16, 2017.
Maimon's colleagues
We found four more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2016.
2016
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2016
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2016
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2016
Tzvi Palash
Protalix BioTherapeutics